These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1720486)

  • 1. Sleep disturbances in hypertension: a double-blind study between isradipine and metoprolol.
    Kantola I; Rauhala E; Erkinjuntti M; Mansury L
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S41-5. PubMed ID: 1720486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First clinical experience with isradipine in the treatment of hypertension in Portugal.
    Rocha-Gonçalves F; Mariano-Pego G; Viegas J; Correia JM; Botelho MA
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S4-6. PubMed ID: 1720485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antihypertensive action of isradipine in mild essential hypertension.
    Viskoper JR; Laszt A; Farragi D
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S9-11. PubMed ID: 1720488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium antagonists as first-line therapy in hypertension: results of the Swiss Isradipine Study. Swiss Hypertension Society.
    Lüscher TF; Waeber B
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S1-3. PubMed ID: 1720476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological modulation of stress-induced cardiovascular hyperreactivity in essential hypertension.
    Schulte W; Rüddel H; Schmieder R; Schächinger H; Bräutigam M; Welzel D
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S70-3. PubMed ID: 1376841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Swedish Isradipine Study in Hypertension: evaluation of quality of life, safety, and efficacy. SWISH Group.
    Jern S; Hansson L; Scherstén B; Kullman S; Sörensen S; Dahlöf B; Eggertsen R; Sivertsson R
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S7-8. PubMed ID: 1720487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of calcium antagonists to treat intra-operative hypertension--evaluation of efficacy and safety of a new dihydropyridine derivative, intravenous isradipine, during abdominal surgery.
    Edouard A; Dartayet B; Ruegg C; Samii K
    Eur J Anaesthesiol; 1991 Sep; 8(5):351-8. PubMed ID: 1834462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antihypertensive effect and adverse effects of isradipine in patients with sever hypertension. Results of an open multicenter study].
    Burger KJ; Dehner R
    Arzneimittelforschung; 1996 Jun; 46(6):600-5. PubMed ID: 8767350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hypertension with dihydropyridine calcium antagonists and aspirin.
    Tison P; Ulicna L; Jakubovska Z; Oravcova J; Fetkovska N
    Blood Press Suppl; 1994; 1():57-60. PubMed ID: 8205303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic, hematological, and cardiac effects of long-term isradipine treatment in mild-to-moderate essential hypertension.
    Meriç M; Gören T; Atilgan D; Eren N; Cubukçu A; Koylan N
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S58-60. PubMed ID: 1376837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized comparison of isradipine slow release given once daily with isradipine twice daily on 24 hour blood pressure in hypertensive patients.
    Christensen HR; Kampmann JP; Simonsen K
    J Hum Hypertens; 1991 Apr; 5(2):121-7. PubMed ID: 1830108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the calcium antagonist isradipine on 24-hour ambulatory blood pressure, platelet aggregation, and neutrophil oxygen free radicals in hypertension.
    Ding YA; Han CL; Chou TC; Lai WY; Shiao MF
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S32-7. PubMed ID: 1376832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Circadian antihypertensive effect of sustained-release isradipine in patients with essential hypertension in comparison to placebo].
    Burger KJ; Anlauf M
    Arzneimittelforschung; 1993 Sep; 43(9):958-62. PubMed ID: 8240458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term antihypertensive and renal effects of isradipine in hypertensive patients with normal and reduced renal function.
    Wittenberg C; Rosenfeld JB
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S93-5. PubMed ID: 1376848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind comparison of the efficacy and safety of lacidipine with atenolol in the treatment of essential hypertension. The United Kingdom Lacidipine Study Group.
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S27-30. PubMed ID: 1726002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
    Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
    Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of isradipine in Type 1 (insulin-dependent) diabetic patients with albuminuria and normal blood pressure.
    Nørgaard K; Jensen T; Feldt-Rasmussen B
    J Hum Hypertens; 1992 Apr; 6(2):145-50. PubMed ID: 1534581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
    Lyngstam O; Rydén L
    Acta Med Scand; 1981; 209(4):261-6. PubMed ID: 7015797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of long-term administration of isradipine on renal hemodynamics and sodium metabolism.
    Francischetti EA; Barroso I; da Silva A; Fagundes VG
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S90-2. PubMed ID: 1376847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of isradipine and metoprolol in treatment of hypertension: the Finnish Isradipine Study in Hypertension (FISH).
    Luomanmäki K; Inkovaara J; Hartikainen M; Helin M; Viikari J; Kataja M; Ekman K; Harjula K
    J Cardiovasc Pharmacol; 1992 Aug; 20(2):296-303. PubMed ID: 1381022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.